These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 21844082

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion.
    Boriani G, Diemberger I, Biffi M, Camanini C, Valzania C, Corazza I, Martignani C, Zannoli R, Branzi A.
    Int J Cardiol; 2005 Jun 08; 101(3):355-61. PubMed ID: 15907401
    [Abstract] [Full Text] [Related]

  • 24. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, Breithardt G, Prevention of Atrial Fibrillation after Cardioversion Investigators.
    Eur Heart J; 2004 Aug 08; 25(16):1385-94. PubMed ID: 15302102
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A decrease in serum aldosterone level is associated with maintenance of sinus rhythm after successful cardioversion of atrial fibrillation.
    Wozakowska-Kaplon B, Bartkowiak R, Janiszewska G.
    Pacing Clin Electrophysiol; 2010 May 08; 33(5):561-5. PubMed ID: 20059712
    [Abstract] [Full Text] [Related]

  • 27. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
    Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ, Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group.
    N Engl J Med; 2002 Dec 05; 347(23):1834-40. PubMed ID: 12466507
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Valsartan for prevention of recurrent atrial fibrillation.
    GISSI-AF Investigators, Disertori M, Latini R, Barlera S, Franzosi MG, Staszewsky L, Maggioni AP, Lucci D, Di Pasquale G, Tognoni G.
    N Engl J Med; 2009 Apr 16; 360(16):1606-17. PubMed ID: 19369667
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
    Márk L, Erdej F, Dani G, Borbély M, Sziklai G, Nagy E, Hajdara I, Katona A.
    Orv Hetil; 2004 May 09; 145(19):1001-6. PubMed ID: 15181735
    [Abstract] [Full Text] [Related]

  • 36. Management of persistent atrial fibrillation following balloon mitral valvotomy: safety and efficacy of low-dose amiodarone.
    Kapoor A, Kumar S, Singh RK, Pandey CM, Sinha N.
    J Heart Valve Dis; 2002 Nov 09; 11(6):802-9. PubMed ID: 12479281
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
    Auer J, Weber T, Berent R, Puschmann R, Hartl P, Ng CK, Schwarz C, Lehner E, Strasser U, Lassnig E, Lamm G, Eber B, Study of Prevention of Postoperative Atrial Fibrillation.
    Am Heart J; 2004 Apr 09; 147(4):636-43. PubMed ID: 15077078
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.